Filter
9005
Filtered Results: 9005
Text search:
in
service
training
Featured
Recommendations
789
New Publications
2519
Language
Document type
No document type
5441
Studies & Reports
1259
Guidelines
974
Manuals
519
Strategic & Response Plan
332
Training Material
201
Fact sheets
113
Situation Updates
87
Resource Platforms
30
Brochures
22
Infographics
10
Online Courses
10
Videos
6
App
1
Countries / Regions
India
379
Global
293
Kenya
292
Ethiopia
207
South Africa
198
Sierra Leone
197
Nepal
195
Uganda
191
Myanmar / Burma
175
Liberia
172
Nigeria
166
Western and Central Europe
155
Bangladesh
146
Zambia
142
Malawi
139
Rwanda
131
Tanzania
128
Syria
121
Africa
117
Ghana
114
Latin America and the Carribbean
91
Ukraine
90
Namibia
86
Philippines
80
Congo, Democratic Republic of
74
South Sudan
73
Lesotho
64
Senegal
62
Zimbabwe
62
Cambodia
61
Indonesia
60
Guinea
58
Eastern Europe
58
Haiti
56
Asia
50
Mozambique
49
South–East Asia Region
47
West and Central Africa
44
East and Southern Africa
43
Burkina Faso
42
Botswana
42
Cameroon
38
Yemen
35
Middle East and North Africa
35
Germany
33
Russia
33
Eswatini/ Swaziland
32
Brazil
31
Afghanistan
28
Pakistan
26
Lebanon
26
Jordan
25
Central African Republic
24
Colombia
23
Eastern Europe and Central Asia
23
Venezuela
23
Somalia
22
Mali
20
Iraq
18
Western Pacific Region
18
Benin
17
Vietnam
17
USA
16
Sudan
16
Thailand
15
Tajikistan
15
Côte d’Ivoire / Ivory Coast
14
Moldova
13
Turkey
12
China
12
Peru
12
Sri Lanka
12
Laos
12
Madagascar
11
Albania
11
Georgia
11
Palestine
10
Chad
7
Papua New Guinea
7
North Macedonia
7
Burundi
7
Libya
7
Southern Africa
7
Timor Leste/ East Timor
7
Iran
7
Togo
6
Gambia
6
Bolivia
6
Greece
6
Mexico
6
Bhutan
6
Niger
5
El Salvador
5
Chile
5
Paraguay
5
Poland
5
Kyrgyzstan
5
Kazakhstan
5
North America
5
Turkmenistan
5
United Kingdom
5
Egypt
4
Argentina
4
Honduras
4
Ecuador
4
Angola
4
Armenia
4
Canada
4
Romania
4
Japan
4
Malaysia
3
Singapore
3
Serbia
3
Hungary
3
Croatia
3
Fiji
3
Mauritius
3
Belarus
3
Bosnia and Herzegovina
3
Guinea-Bissau
2
Saudi Arabia
2
Mauritania
2
Ireland
2
Guatemala
2
Mongolia
2
Bulgaria
2
Estonia
2
Lithuania
2
Uzbekistan
2
Jamaica
2
Portugal
2
Spain
2
Azerbaijan
2
Morocco
1
Vanuatu
1
Dominican Republic
1
Switzerland
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Djibouti
1
Qatar
1
Slovakia
1
Australia
1
Gabon
1
Belgium
1
France
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
3508
Clinical Guidelines
604
Women & Child Health
541
Public Health
483
Key Resources
437
Capacity Building
276
Pharmacy & Technologies
88
Annual Report MEDBOX
3
Toolboxes
Mental Health
778
COVID-19
629
HIV
606
Disability
499
TB
394
Caregiver
314
Conflict
293
Ebola
276
Planetary Health
245
Rapid Response
242
AMR
219
Refugee
183
NTDs
178
Pharmacy
153
Natural Hazards
146
Global Health Education
120
NCDs
116
Cholera
58
Specific Hazards
53
Health Financing Toolbox
49
Social Ethics
46
Polio
42
Zika
37
Typhoon
4
South Sudan
2
Health Financing
2
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available ... all settings, especially in rural areas of low-income countries, making it difficult to identify and treat patients. Additionally, there is controversy about the role, type and duration of anthelmintic, antiinflammatory and antiepileptic drug (AED) treatments for different forms of neurocysticercosis.
These guidelines were developed to assist health-care providers in appropriate, evidence-based management of parenchymal neurocysticercosis. The guidelines do not address other forms of neurocysticercosis and do not include management of extraparenchymal disease (including cysticerci in the cerebral ventricles or subarachnoid space). The aim of the guidance is to improve decision-making to ensure appropriate patient care and to avoid misdiagnoses and inappropriate treatment of patients with neurocysticercosis.
This summary covers the preventive approach to breast cancer control and includes prophylactic medications, prophylactic surgery and lifestyle modifications for breast cancer prevention. Health professional training and individual risk assessments a...
Women Cancer
recommended
MEDBOX Issue Brief No.17, 21 November 2021
Women's cancers have a significant impact on women's health worldwide. According to the World Health Organisation, nearly three million women are diagnosed with breast or cervical cancer every year. In th...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Buku Pegangan -Panduan penilaian dan alur layanan berbasis individu di layanan kesehatan primer
recommended
Indonesian Version of: Integrated care for older people (ICOPE): guidance for person-centred assessment and pathways in primary care. The ICOPE guidance for person-centred assessment and pathways in<...
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI...
Reliable cause specic mortality statistics are the cornerstone of national health information
systems. They are essential for evidence-based decision making for monitoring health of
populations, health services planning and delivery, programme ...
This brief advocacy document highlights the burden, risks and prevention of injuries and violence, which took the lives of 4.4 million people in 2019 and constitute 8% of all deaths. Among the injury-related causes of death include road traffic cras...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...
This document provides an overview of WHO's Refugee and migrant health toolkit, a web-based one-stop comprehensive platform of tools and resources to support the global, regional, and country efforts in implementing health and migration-related acti...
The Food and Agriculture Organization of the United Nations (FAO) launched a new Framework for Environmental and Social Management (FESM) to ensure that both people and the environment are protected from any potential impacts of FAO programmes and projects.
“This Framework ensures that our proj...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD D...
Making sure that people with disabilities get the right health care to do with their bodies, sex, relationships and having children during COVID-19
About this information
This information is about health care for people with disabilities to do with their bodies, sex, relationships and having c...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmanias...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi...
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss ... working adult populations. Patients with severe levels of DR are reported to have poorer quality of life and reduced levels of physical, emotional, and social well-being, and they utilize more health care resources.
Epidemiological studies and clinical trials have shown that optimal control of blood glucose, blood pressure, and blood lipids can reduce the risk of developing retinopathy and slow its progression. Timely treatment with laser photocoagulation, and increasingly, the appropriate use of intraocular administration of vascular endothelial growth factor (VEGF) inhibitors can prevent visual loss in vision- threatening retinopathy, particularly diabetic macular edema (DME). Since visual loss may not be present in the earlier stages of retinopathy, regular screening of persons with diabetes is essential to enable early intervention.
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of dis...
